Barry Kagan, a director of Dipexium Pharmaceuticals, Inc., just received 18,000 options from the company. The strike price of the options received was $10.16, and these expire on January 19, 2026. Kagan now owns at least 18,000 options on the company.
Some additional info was provided as follows:
Options vest as follows: 50% on the date of grant and the remaining 50% vests in equal installments over a 24 month period.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following: